Beyond its reported anti-proliferative activity in CRC cells [110], ILA enhances IL-12 secretion by DCs through chromatin remodeling, thereby priming CD8+ T-cell immunity against tumor growth; ILA also improves the function of tumor-infiltrating CD8+ T cells [111]. The gene discussed is TNFRSF9; the disease is colorectal carcinoma.